93
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Mortality and molecular epidemiology associated with extended-spectrum β-lactamase production in Escherichia coli from bloodstream infection

, , , , , , , , & show all
Pages 57-62 | Published online: 13 Mar 2014

References

  • CoqueTMBaqueroFCantonRIncreasing prevalence of ESBL-producing Enterobacteriaceae in EuropeEuro Surveill200813471904419021958
  • SchwaberMJCarmeliYMortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysisJ Antimicrob Chemother200760591392017848376
  • TumbarelloMSpanuTDi BidinoRCosts of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapyAntimicrob Agents Chemother201054104085409120660675
  • de KrakerMEWolkewitzMDaveyPGBurden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporinsJ Antimicrob Chemother201166239840721106563
  • NasaPJunejaDSinghODangRSinghAAn observational study on bloodstream extended-spectrum beta-lactamase infection in critical care unit: incidence, risk factors and its impact on outcomeEur J Intern Med201223219219522284253
  • StewardsonAFankhauserCDe AngelisGBurden of bloodstream infection caused by extended-spectrum β-lactamase-producing enterobacteriaceae determined using multistate modeling at a Swiss University Hospital and a nationwide predictive modelInfect Control Hosp Epidemiol201334213314323295559
  • ThygesenSKChristiansenCFChristensenSLashTLSorensenHTThe predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of PatientsBMC Med Res Methodol2011118321619668
  • Clinical and Laboratory Standards InstitutePerformance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational SupplementWayne (PA)CLSI2007
  • GröbnerSLinkeDSchützWEmergence of carbapenem-nonsusceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, GermanyJ Med Microbiol200958Pt 791292219502377
  • Pérez-PérezFJHansonNDDetection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCRJ Clin Microbiol20024062153216212037080
  • ClermontOBonacorsiSBingenERapid and simple determination of the Escherichia coli phylogenetic groupAppl Environ Microbiol200066104555455811010916
  • Rodríguez-BañoJMingoranceJFernández-RomeroNSerranoLLópez-CereroLPascualAOutcome of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli: impact of microbiological determinantsJ Infect2013671273423588104
  • FrakkingFNRottierWCDorigo-ZetsmaJWAppropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-β-lactamase-producing bacteriaAntimicrob Agents Chemother20135773092309923612198
  • PeraltaGLameloMAlvarez-GarcíaPImpact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort studyBMC Infect Dis20121224523038999
  • CantónRAkóvaMCarmeliYRapid evolution and spread of carbapenemases among Enterobacteriaceae in EuropeClin Microbiol Infect201218541343122507109
  • RottierWCAmmerlaanHSBontenMJEffects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysisJ Antimicrob Chemother20126761311132022396430
  • Rodríguez-BañoJPicónEGijónPRisk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coliJ Clin Microbiol20104851726173120181897
  • KolaAKohlerCPfeiferYHigh prevalence of extended-spectrum-β-lactamase-producing Enterobacteriaceae in organic and conventional retail chicken meat, GermanyJ Antimicrob Chemother201267112631263422868643
  • LeistnerRMeyerEGastmeierPPfeiferYEllerCDemPRisk factors associated with the community-acquired colonization of extended-spectrum beta-lactamase (ESBL) positive Escherichia coli. An exploratory case-control studyPLoS One201389e7432324040229
  • Ojer-UsozEGonzálezDVitasAIPrevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae in meat products sold in Navarra, SpainMeat Sci201393231632123062714
  • Nicolas-ChanoineMHBlancoJLeflon-GuiboutVIntercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15J Antimicrob Chemother200861227328118077311
  • VoetsGMPlatteelTNFluitACPopulation distribution of beta-lactamase conferring resistance to third-generation cephalosporins in human clinical Enterobacteriaceae in The NetherlandsPLoS One2012712e5210223284886
  • ReulandEAOverdevestITAl NaiemiNHigh prevalence of ESBL-producing Enterobacteriaceae carriage in Dutch community patients with gastrointestinal complaintsClin Microbiol Infect201319654254922757622
  • IzdebskiRBaraniakAFiettJClonal structure, extended-spectrum β-lactamases, and acquired AmpC-type cephalosporinases of Escherichia coli populations colonizing patients in rehabilitation centers in four countriesAntimicrob Agents Chemother201357130931623114774
  • EwersCBetheASemmlerTGuentherSWielerLHExtended-spectrum β-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspectiveClin Microbiol Infect201218764665522519858